SRI Blog

Biomedical Sciences and Health

Michael MooneyLidia Sambucetti Feb 19, 2014 Comments (1)

For years, there has been a major unmet need for a more sensitive method for improved identification and characterization of rare circulating tumor cells (CTCs), blood markers that can identify tumors that are metastasizing and spreading.

Michael MooneyGita Shankar & Walter H. Moos Nov 1, 2013 Comments (2)

At SRI International, researchers are pursuing advances in antidotes and treatments such as oral medication that could be given to mass populations in the event of a disaster such as radiation exposure.

Michael MooneyStephen Morairty Jul 26, 2013 Comments (11)

Researchers in SRI's Center for Neuroscience are searching for a biomarker that could help diagnose neurodegenerative diseases years before symptoms appear and brain damage is already extensive.

AnonymousRajeev Vaidyanathan Jul 18, 2013 Comments (6)

Bed bugs are truly egalitarian. In time, more incidents of bed bugs are expected in middle-class and higher-income homes. Now, let's talk about hard numbers and solutions.

Michael MooneyJennifer W. Yu May 20, 2013 Comments (2)

DSM-5’s new Autism Spectrum Disorder (ASD) diagnosis is a significant change that can lead to more individualized diagnostic approaches for people with ASD. It may increase the sensitivity and clarity of clinicians’ diagnoses as they consider the needs, symptoms, and severity of each patient.

Denong WangDenong Wang May 8, 2013 Comments (4)

SRI’s Tumor Glycome Laboratory has found a biomarker that identifies the most aggressive form of prostate cancer. Further study will confirm if a blood test can provide a much-needed tool to differentiate between aggressive cancer and the majority of cases which are slow-growing tumors.

Joseph Rogers Feb 8, 2013 Comments (0)

SRI is taking an innovative approach that recognizes and attempts to address the emerging concept that Alzheimer’s could be a syndrome, with multiple causes and incestuously-interlocked effects.

Gary Swan Dec 17, 2012 Comments (2)

Through twin studies, scientists understand the interplay between genetics and the environment in ways that the study of unrelated people–or even other types of siblings–is unable to do.

Marty RitcheyRajeev Vaidyanathan Dec 5, 2012 Comments (31)

Bed bugs share our beds, feed on our blood at night, and they disappear by dawn, often leaving nothing more than a raised welt on our skin, a token of last night’s encounter. Why is it so hard to prevent and control them?

Jon C. Mirsalis Sep 13, 2012 Comments (2)

Traditional pharmaceutical companies simply can’t afford to spend the $1 billion or more it takes to bring a drug all the way to market when the affected population is too poor to buy the drugs, or too small to make a dent in the investment. Organizations like SRI fill the gap.

Kristen KenedyRajeev Vaidyanathan Jul 19, 2012 Comments (16)

Bed bug bites can cause adverse reactions such as rashes, lesions, allergies, and psychological distress, and the pests most significantly impact the most vulnerable in our society.

Keith R. Laderoute Jun 27, 2012 Comments (2)

Recent work in SRI's Cancer Biology Program indicates that an enzyme that regulates ATP - the cell’s fuel sensor - could hold a key to suppressing some aggressive tumors.